{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:20Z","timestamp":1789154420497,"version":"build-2803163510"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,5,15]]},"DOI":"10.2169\/internalmedicine.4835-24","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T22:14:39Z","timestamp":1741990479000},"page":"1547-1551","source":"Crossref","is-referenced-by-count":1,"title":["A Severe Case of Rhabdomyolysis Requiring Renal Replacement Therapy Following COVID-19 mRNA Vaccination"],"prefix":"10.2169","volume":"64","author":[{"given":"Motohiro","family":"Ueda","sequence":"first","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Uchimura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie","family":"Ohkoshi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Saegusa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Osano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Medicine, University of Yamanashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner J 15: 58-69, 2015."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sheka M, Coattrenec Y, Lorenzini KI, Nendaz M. A severe case of rhabdomyolysis after Moderna mRNA anti-COVID-19 vaccine with a literature review. Clin Case Rep 11: e7184, 2023.","DOI":"10.1002\/ccr3.7184"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nassar M, Chung H, Dhayaparan Y, et al. COVID-19 vaccine induced rhabdomyolysis: case report with literature review. Diabetes Metab Syndr 15: 102170, 2021.","DOI":"10.1016\/j.dsx.2021.06.007"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ajmera KM. Fatal Case of Rhabdomyolysis Post-COVID-19 Vaccine. Infect Drug Resist 14: 3929-3935, 2021.","DOI":"10.2147\/IDR.S331362"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kamura Y, Terao T, Akao S, Kono Y, Honma K, Matsue K. Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA-1273 vaccine: a case report. Int J Infect Dis 117: 322-325, 2022.","DOI":"10.1016\/j.ijid.2022.02.031"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Huang ST, Lee TJ, Chen KH, et al. Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination. J Microbiol Immunol Infect 55 (6 Pt 1): 1131-1133, 2022.","DOI":"10.1016\/j.jmii.2022.04.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ruijters VJ, van der Meulen MFG, van Es MA, Smit T, Hoogendijk JE. Rhabdomyolysis after COVID-19 Comirnaty vaccination: a case report. Case Rep Neurol 14: 429-432, 2022.","DOI":"10.1159\/000527599"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Banamah TA, Bogari AA, Neyazi A, Kotbi E, Almaghraby H, Atwah F. Severe rhabdomyolysis complicated with acute kidney injury required renal replacement therapy after Pfizer COVID-19 vaccine. Cureus 14: e25199, 2022.","DOI":"10.7759\/cureus.25199"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol 11: 617089, 2020.","DOI":"10.3389\/fimmu.2020.617089"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pucchio A, Akiva MH, Evangeliou H, Papenburg J, Salvadori MI. Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager. Pediatr Nephrol (Berlin, Germany) 38: 1979-1983, 2023.","DOI":"10.1007\/s00467-022-05808-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cirillo E, Esposito C, Giardino G, et al. Case report: severe rhabdomyolysis and multiorgan failure after ChAdOx1 nCoV-19 vaccination. Front Immunol 13: 845496, 2022.","DOI":"10.3389\/fimmu.2022.845496"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li J, Uetrecht JP. The danger hypothesis applied to idiosyncratic drug reactions. Handb Exp Pharmacol 196: 493-509, 2010.","DOI":"10.1007\/978-3-642-00663-0_18"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 361: 62-72, 2009.","DOI":"10.1056\/NEJMra0801327"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Grivei A, Giuliani KTK, Wang X, et al. Oxidative stress and inflammasome activation in human rhabdomyolysis-induced acute kidney injury. Free Radic Biol Med 160: 690-695, 2020.","DOI":"10.1016\/j.freeradbiomed.2020.09.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liu ZZ, Mathia S, Pahlitzsch T, et al. Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles. Am J Physiol Renal Physiol 312: F908-F916, 2017.","DOI":"10.1152\/ajprenal.00394.2016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care (London, England) 18: 224, 2014.","DOI":"10.1186\/cc13897"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Korantzopoulos P, Galaris D, Papaioannides D. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 28: 1185; author reply 1186, 2002.","DOI":"10.1007\/s00134-002-1356-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mikkelsen TS, Toft P. Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis. Acta Anaesthesiol Scand 49: 859-864, 2005.","DOI":"10.1111\/j.1399-6576.2005.00577.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang Q, Qi G, Zhou H, et al. Protective effect of thymol on glycerol-induced acute kidney injury. Ren Fail 45: 2227728, 2023.","DOI":"10.1080\/0886022X.2023.2227728"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hirayama Y, Oda S, Wakabayashi K, et al. Comparison of interleukin-6 removal properties among hemofilters consisting of varying membrane materials and surface areas: an in vitro study. Blood Purif 31: 18-25, 2011.","DOI":"10.1159\/000321142"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Oshihara W, Fujieda H, Ueno Y. A new poly(methyl methacrylate) membrane dialyzer, NF, with adsorptive and antithrombotic properties. Contrib Nephrol 189: 230-236, 2017.","DOI":"10.1159\/000450806"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Imhof C, Messchendorp AL, Martiniere H, Gansevoort RT. Severe rhabdomyolysis after COVID-19 vaccine. Ann Intern Med Clin Cases 1: e220215, 2022.","DOI":"10.7326\/aimcc.2022.0215"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/10\/64_4835-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:27:05Z","timestamp":1747452425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/10\/64_4835-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4835-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"4835-24"}}